Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chesapeake Emerging Opportunities (CEO) is a healthcare data services organization and a collaborative initiative between the Chesapeake Regional Information System for our Patients (CRISP), Johns Hopkins University, and the University of Maryland. The entity provides a specialized platform that grants researchers secure access to de-identified, longitudinal clinical data from Maryland's statewide health information exchange (HIE). By facilitating large-scale 'Big Data' analytics, CEO supports a wide range of life science research, including population health studies, clinical outcomes analysis, and the development of real-world evidence. The organization serves as a vital infrastructure component for academic and commercial researchers seeking to leverage comprehensive clinical datasets to improve healthcare delivery and patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chesapeake Emerging Opportunities.